| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | -100.0% |
| R&D Expense | $33.8M | — | +117.2% |
| SG&A Expense | $9.7M | — | +18.6% |
| Operating Income | -$43.5M | — | -103.0% |
| Income Tax | $0 | — | — |
| Net Income | -$42.4M | — | -97.0% |
| EPS (Basic) | -$0.12 | — | -50.0% |
| EPS (Diluted) | -$0.12 | — | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $276.6M | -13.5% | +137.2% |
| Current Assets | $282.3M | -13.1% | +133.8% |
| Total Assets | $300.4M | -12.5% | +117.1% |
| Current Liabilities | $20.1M | -24.3% | -10.9% |
| Long-term Debt | $49.0M | -2.3% | +15.3% |
| Total Liabilities | $88.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$40.9M | — | -85.6% |
| Capital Expenditures | $24K | — | -93.7% |
| Investing Cash Flow | -$3.0M | — | -715.1% |
| Financing Cash Flow | $711K | — | +1467.3% |
| Free Cash Flow | -$40.9M | — | -82.6% |
| +6.1% |
| Stockholders' Equity | $211.9M | -14.2% | +284.9% |